Hyperuricemia and Cardiovascular Risk

Area of Science:

• Cardiovascular Medicine
• Rheumatology
• Metabolic Disorders

Background:

• Increasing prevalence of hyperuricemia (elevated serum uric acid) raises concerns about cardiovascular risk.
• Established link between hyperuricemia and the development of gout, an inflammatory joint condition.
• Growing scientific interest in the association between uric acid levels and cardiovascular disease (CVD).

Purpose of the Study:

• To review the relationship between gout and cardiovascular disease risk.
• To explore the pathophysiology of gout and its contribution to CVD.
• To discuss interdisciplinary management strategies and future research directions for gout.

Main Methods:

• Literature review of studies investigating hyperuricemia, gout, and cardiovascular outcomes.
• Analysis of pathophysiological mechanisms linking gout to cardiovascular complications.
• Synthesis of current understanding on gout management and research gaps.

Main Results:

• Hyperuricemia is strongly associated with an increased risk of developing gout.
• Evidence suggests a significant link between elevated uric acid levels and heightened cardiovascular disease risk.
• Understanding gout pathophysiology is crucial for assessing its impact on cardiovascular health.

Conclusions:

• Gout and cardiovascular disease share common risk factors and pathophysiological pathways.
• Effective management of gout may positively impact cardiovascular outcomes.
• Further interdisciplinary research is needed to optimize diagnosis and treatment for patients with gout and comorbid CVD.